| MeSH term | MeSH ID | Detail |
|---|---|---|
| Carcinoma | D002277 | 18 associated lipids |
| Carcinoma, Non-Small-Cell Lung | D002289 | 72 associated lipids |
| Carcinoma, Papillary | D002291 | 3 associated lipids |
| Carcinosarcoma | D002296 | 7 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Celiac Disease | D002446 | 16 associated lipids |
| Brain Ischemia | D002545 | 89 associated lipids |
| Cherubism | D002636 | 1 associated lipids |
| Chondroblastoma | D002804 | 1 associated lipids |
| Chondrocalcinosis | D002805 | 1 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Kim SD et al. | Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice. | 2013 | Biochem. Pharmacol. | pmid:23928189 |
| Ben-Tal Cohen E et al. | Statins decrease TNF-alpha-induced osteoprotegerin production by endothelial cells and smooth muscle cells in vitro. | 2007 | Biochem. Pharmacol. | pmid:17070781 |
| Takeuchi T et al. | Adrenergic stimulation of osteoclastogenesis mediated by expression of osteoclast differentiation factor in MC3T3-E1 osteoblast-like cells. | 2001 | Biochem. Pharmacol. | pmid:11239501 |
| Yamagami H et al. | Inhibition of osteoclastogenesis by a phosphodiesterase 4 inhibitor XT-611 through synergistic action with endogenous prostaglandin E2. | 2003 | Biochem. Pharmacol. | pmid:12948861 |
| Kim HH et al. | Inhibition of osteoclast differentiation and bone resorption by tanshinone IIA isolated from Salvia miltiorrhiza Bunge. | 2004 | Biochem. Pharmacol. | pmid:15081864 |
| Theoleyre S et al. | Cellular activity and signaling induced by osteoprotegerin in osteoclasts: involvement of receptor activator of nuclear factor kappaB ligand and MAPK. | 2004 | Biochim. Biophys. Acta | pmid:14741739 |
| Kuo PL et al. | MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein. | 2013 | Biochim. Biophys. Acta | pmid:23458685 |
| Lamoureux F et al. | Regulation of osteoprotegerin pro- or anti-tumoral activity by bone tumor microenvironment. | 2010 | Biochim. Biophys. Acta | pmid:19733222 |
| Wittrant Y et al. | RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis. | 2004 | Biochim. Biophys. Acta | pmid:15363860 |
| Pulsatelli L et al. | Soluble receptor activator of nuclear factor- kappaB Ligand (sRANKL)/osteoprotegerin balance in ageing and age-associated diseases. | 2004 | Biogerontology | pmid:15105586 |
| Chondrogianni N et al. | Cloning of differentially expressed genes in skin fibroblasts from centenarians. | 2004 | Biogerontology | pmid:15609104 |
| Chen X et al. | Cadmium stimulates the osteoclastic differentiation of RAW264.7 cells in presence of osteoblasts. | 2012 | Biol Trace Elem Res | pmid:22076734 |
| Liang D et al. | Zinc upregulates the expression of osteoprotegerin in mouse osteoblasts MC3T3-E1 through PKC/MAPK pathways. | 2012 | Biol Trace Elem Res | pmid:22081405 |
| Ren G et al. | Simultaneous administration of fluoride and selenite regulates proliferation and apoptosis in murine osteoblast-like MC3T3-E1 cells by altering osteoprotegerin. | 2011 | Biol Trace Elem Res | pmid:21739163 |
| Yu J et al. | Effect of fluoride and low versus high levels of dietary calcium on mRNA expression of osteoprotegerin and osteoprotegerin ligand in the bone of rats. | 2013 | Biol Trace Elem Res | pmid:23456427 |
| Srivastava S et al. | Role of vanadium (V) in the differentiation of C3H10t1/2 cells towards osteoblast lineage: a comparative analysis with other trace elements. | 2013 | Biol Trace Elem Res | pmid:23325289 |
| Suh KS et al. | Kaempferol attenuates 2-deoxy-d-ribose-induced oxidative cell damage in MC3T3-E1 osteoblastic cells. | 2009 | Biol. Pharm. Bull. | pmid:19336918 |
| Ono Y et al. | Suppressive effect of Kanzo-bushi-to, a Kampo medicine, on collagen-induced arthritis. | 2004 | Biol. Pharm. Bull. | pmid:15340228 |
| Kim JY et al. | (2S)-2'-Methoxykurarinone inhibits osteoclastogenesis and bone resorption through down-regulation of RANKL signaling. | 2014 | Biol. Pharm. Bull. | pmid:24492722 |
| Xie F et al. | Increase in bone mass and bone strength by Sambucus williamsii HANCE in ovariectomized rats. | 2005 | Biol. Pharm. Bull. | pmid:16204939 |
| Kanematsu M et al. | [Effects of gravity on the gene expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor]. | 1999 | Biol. Sci. Space | pmid:12532992 |
| Kanematsu M et al. | [Clinostat rotation culture modulates gene expression of osteoclastogenesis-regulating factors via a cyclic-AMP dependent mechanism]. | 2000 | Biol. Sci. Space | pmid:12561872 |
| Gordon IK and Camphausen K | Research highlights. | 2011 | Biomark Med | pmid:21861664 |
| Milone F et al. | Assessment and clinical implications of RANK/RANKL/OPG pathway as markers of bone tumor progression in patients with NET harboring bone metastases. | 2013 | Biomarkers | pmid:23336103 |
| Song TJ et al. | Association of plasma osteoprotegerin levels with stroke severity and functional outcome in acute ischaemic stroke patients. | 2012 | Biomarkers | pmid:23030274 |
| Schwartz Z et al. | Mechanisms regulating increased production of osteoprotegerin by osteoblasts cultured on microstructured titanium surfaces. | 2009 | Biomaterials | pmid:19395022 |
| Wang L et al. | Integrin beta1 silencing in osteoblasts alters substrate-dependent responses to 1,25-dihydroxy vitamin D3. | 2006 | Biomaterials | pmid:16569430 |
| Robinson DE et al. | Glycosaminoglycan (GAG) binding surfaces for characterizing GAG-protein interactions. | 2012 | Biomaterials | pmid:22079008 |
| Findlay DM et al. | The proliferation and phenotypic expression of human osteoblasts on tantalum metal. | 2004 | Biomaterials | pmid:14741587 |
| Crotti TN et al. | Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappaB, RANK ligand and osteoprotegerin. | 2004 | Biomaterials | pmid:14607494 |
| Wiens M et al. | The role of biosilica in the osteoprotegerin/RANKL ratio in human osteoblast-like cells. | 2010 | Biomaterials | pmid:20673584 |
| Chai YC et al. | Ectopic bone formation by 3D porous calcium phosphate-Ti6Al4V hybrids produced by perfusion electrodeposition. | 2012 | Biomaterials | pmid:22381474 |
| Granchi D et al. | Bone cement extracts modulate the osteoprotegerin/osteoprotegerin-ligand expression in MG63 osteoblast-like cells. | 2002 | Biomaterials | pmid:12013183 |
| Thormann U et al. | Bone formation induced by strontium modified calcium phosphate cement in critical-size metaphyseal fracture defects in ovariectomized rats. | 2013 | Biomaterials | pmid:23906515 |
| Salbach-Hirsch J et al. | The promotion of osteoclastogenesis by sulfated hyaluronan through interference with osteoprotegerin and receptor activator of NF-κB ligand/osteoprotegerin complex formation. | 2013 | Biomaterials | pmid:23871544 |
| Vallés G et al. | Modulation of the cross-talk between macrophages and osteoblasts by titanium-based particles. | 2008 | Biomaterials | pmid:18313744 |
| Sandor M et al. | A novel polyethylene depot device for the study of PLGA and P(FASA) microspheres in vitro and in vivo. | 2002 | Biomaterials | pmid:12219832 |
| Ren W et al. | Distinct gene expression of receptor activator of nuclear factor-kappaB and rank ligand in the inflammatory response to variant morphologies of UHMWPE particles. | 2003 | Biomaterials | pmid:14530078 |
| Holding CA et al. | The correlation of RANK, RANKL and TNFalpha expression with bone loss volume and polyethylene wear debris around hip implants. | 2006 | Biomaterials | pmid:16806459 |
| Zhao G et al. | Requirement for both micron- and submicron scale structure for synergistic responses of osteoblasts to substrate surface energy and topography. | 2007 | Biomaterials | pmid:17368532 |
| Kim YH et al. | Enhancement of bone regeneration by dual release of a macrophage recruitment agent and platelet-rich plasma from gelatin hydrogels. | 2014 | Biomaterials | pmid:24125774 |
| Pioletti DP and Kottelat A | The influence of wear particles in the expression of osteoclastogenesis factors by osteoblasts. | 2004 | Biomaterials | pmid:15172492 |
| Haynes DR et al. | Regulation of osteoclast activity in peri-implant tissues. | 2004 | Biomaterials | pmid:15109848 |
| Zhang T et al. | The effect of osteoprotegerin gene modification on wear debris-induced osteolysis in a murine model of knee prosthesis failure. | 2009 | Biomaterials | pmid:19665222 |
| Wang Y et al. | The effect of adenovirus-mediated siRNA targeting BMPR-II on UHMWPE-induced osteoclast formation. | 2013 | Biomaterials | pmid:23079666 |
| Masui T et al. | Expression of inflammatory cytokines, RANKL and OPG induced by titanium, cobalt-chromium and polyethylene particles. | 2005 | Biomaterials | pmid:15576143 |
| Van Schepdael A et al. | A mechanobiological model of orthodontic tooth movement. | 2013 | Biomech Model Mechanobiol | pmid:22539046 |
| Zong ming W et al. | Bone formation in rabbit cancellous bone explant culture model is enhanced by mechanical load. | 2013 | Biomed Eng Online | pmid:23597232 |
| Huang C et al. | The inhibitory effect of strontium-doped calcium polyphosphate particles on cytokines from macrophages and osteoblasts leading to aseptic loosening in vitro. | 2014 | Biomed Mater | pmid:24518283 |
| Tang T et al. | Effect of water-soluble P-chitosan and S-chitosan on human primary osteoblasts and giant cell tumor of bone stromal cells. | 2011 | Biomed Mater | pmid:21205994 |
| Rieder P et al. | TiNOx coatings increase human primary osteoblasts proliferation independently of the substrate: a short report. | 2012 | Biomed Mater Eng | pmid:23023144 |
| Stejskal D et al. | Osteoprotegerin, RANK, RANKL. | 2001 | Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub | pmid:12426773 |
| Stejskal D et al. | Osteoprotegerin and bone density. | 2001 | Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub | pmid:12426776 |
| Navratilova Z et al. | Osteoprotegerin gene polymorphism is not associated with prosthetic joint infection after total joint arthroplasty in the Czech population. | 2014 | Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub | pmid:22660233 |
| Luo J et al. | 1,25-dihydroxyvitamin D3 inhibits the RANKL pathway and impacts on the production of pathway-associated cytokines in early rheumatoid arthritis. | 2013 | Biomed Res Int | pmid:23710436 |
| Rewiuk K and Grodzicki T | Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation. | 2015 | Biomed Res Int | pmid:26504794 |
| MankoÄ RamuÅ¡ S et al. | SNP rs2073618 of the osteoprotegerin gene is associated with diabetic retinopathy in Slovenian patients with type 2 diabetes. | 2013 | Biomed Res Int | pmid:24228244 |
| Wang F et al. | Association analysis between g.18873C>T and g.27522G>A genetic polymorphisms of OPG and bone mineral density in Chinese postmenopausal women. | 2014 | Biomed Res Int | pmid:25580430 |
| Irtyuga O et al. | NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL. | 2017 | Biomed Res Int | pmid:28246602 |
| Bolamperti S et al. | Evidence for Altered Canonical Wnt Signaling in the Trabecular Bone of Elderly Postmenopausal Women with Fragility Femoral Fracture. | 2016 | Biomed Res Int | pmid:27999816 |
| Bernardi S et al. | Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease. | 2016 | Biomed Res Int | pmid:27200369 |
| Milstead JR et al. | Spaceflight and hindlimb suspension disuse models in mice. | 2004 | Biomed Sci Instrum | pmid:15133943 |
| Jia L and Jin TY | Combined effect of fluoride and arsenate on gene expression of osteoclast differentiation factor and osteoprotegerin. | 2006 | Biomed. Environ. Sci. | pmid:17190191 |
| Sun J et al. | Proliferation and gene expression of osteoblasts cultured in DMEM containing the ionic products of dicalcium silicate coating. | 2009 | Biomed. Pharmacother. | pmid:19231130 |
| Tarquini R et al. | Circasemidian rather than circadian variation of circulating osteoprotegerin in clinical health. | 2005 | Biomed. Pharmacother. | pmid:16275499 |
| Goto H et al. | Human bone marrow adipocytes support dexamethasone-induced osteoclast differentiation and function through RANKL expression. | 2011 | Biomed. Res. | pmid:21383509 |
| Hanmoto T et al. | Effects of low-intensity pulsed ultrasound on osteoclasts: Analysis with goldfish scales as a model of bone. | 2017 | Biomed. Res. | pmid:28239034 |
| Masuki H et al. | Immunolocalization of DMP1 and sclerostin in the epiphyseal trabecule and diaphyseal cortical bone of osteoprotegerin deficient mice. | 2010 | Biomed. Res. | pmid:21079361 |
| Marshall AJ et al. | Long-chain triazolyl acids as inhibitors of osteoclastogenesis. | 2013 | Bioorg. Med. Chem. | pmid:23726411 |
| Shi W et al. | Osteoprotegerin is up-regulated in pancreatic cancers and correlates with cancer-associated new-onset diabetes. | 2014 | Biosci Trends | pmid:25641178 |
| Singh K et al. | An amperometric immunosensor for osteoproteogerin based on gold nanoparticles deposited conducting polymer. | 2008 | Biosens Bioelectron | pmid:18304799 |
| Skládal P et al. | Investigation of osteoprotegerin interactions with ligands and antibodies using piezoelectric biosensors. | 2005 | Biosens Bioelectron | pmid:15741072 |
| Gruber HE and Rude RK | Alterations in osteoclast morphology following osteoprotegerin administration in the magnesium-deficient mouse. | 2003 | Biotech Histochem | pmid:14989640 |
| Han W et al. | Construction of a new tumour necrosis factor fusion-protein expression vector for high-level expression of heterologous genes in Escherichia coli. | 2003 | Biotechnol. Appl. Biochem. | pmid:12630898 |
| Todenhöfer T et al. | Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy. | 2014 | BJU Int. | pmid:23360112 |
| Secchiero P et al. | Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells. | 2008 | Blood | pmid:18000166 |
| Dewar AL et al. | Imatinib as a potential antiresorptive therapy for bone disease. | 2006 | Blood | pmid:16449525 |
| Bosshart H | Expression of survival receptors in Hodgkin disease cell lines. | 2002 | Blood | pmid:12001908 |
| Børset M et al. | Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins. | 2000 | Blood | pmid:11001907 |
| Standal T et al. | Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells. | 2002 | Blood | pmid:12351414 |
| Sezer O et al. | RANK ligand and osteoprotegerin in myeloma bone disease. | 2003 | Blood | pmid:12424190 |
| Yamada T et al. | Regulation of osteoclast development by Notch signaling directed to osteoclast precursors and through stromal cells. | 2003 | Blood | pmid:12411305 |
| Yang M et al. | Chemokine and chemokine receptor expression during colony stimulating factor-1-induced osteoclast differentiation in the toothless osteopetrotic rat: a key role for CCL9 (MIP-1gamma) in osteoclastogenesis in vivo and in vitro. | 2006 | Blood | pmid:16304045 |
| Qiang YW et al. | Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma. | 2008 | Blood | pmid:18305214 |
| Cremer I et al. | Long-lived immature dendritic cells mediated by TRANCE-RANK interaction. | 2002 | Blood | pmid:12393586 |
| Giuliani N et al. | Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease. | 2002 | Blood | pmid:12393684 |
| Zauli G et al. | Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo. | 2007 | Blood | pmid:17363729 |
| Lean JM et al. | FLT3 ligand can substitute for macrophage colony-stimulating factor in support of osteoclast differentiation and function. | 2001 | Blood | pmid:11675341 |
| Fiumara P et al. | Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines. | 2001 | Blood | pmid:11675352 |
| Colucci S et al. | T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction. | 2004 | Blood | pmid:15308561 |
| Terpos E et al. | Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index. | 2003 | Blood | pmid:12689925 |
| Zheng B et al. | MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival. | 2003 | Blood | pmid:12689928 |
| Moreno JL et al. | IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL. | 2003 | Blood | pmid:12689929 |
| Seidel C et al. | Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease. | 2001 | Blood | pmid:11568016 |
| Miyamoto T et al. | Bifurcation of osteoclasts and dendritic cells from common progenitors. | 2001 | Blood | pmid:11588053 |
| Sauer AV et al. | ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency. | 2009 | Blood | pmid:19633200 |
| Bengtsson AK et al. | 17beta-estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells. | 2004 | Blood | pmid:15142882 |
| Chagraoui H et al. | Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO. | 2003 | Blood | pmid:12506018 |
| Nosaka K et al. | Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor kappaB ligand on adult T-cell leukemia cells. | 2002 | Blood | pmid:11781248 |
| Giuliani N et al. | Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment. | 2001 | Blood | pmid:11739153 |